| Product NDC: | 25021-120 |
| Proprietary Name: | Cefuroxime |
| Non Proprietary Name: | cefuroxime sodium |
| Active Ingredient(s): | 7.5 g/82.5mL & nbsp; cefuroxime sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-120 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065046 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080501 |
| Package NDC: | 25021-120-59 |
| Package Description: | 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL |
| NDC Code | 25021-120-59 |
| Proprietary Name | Cefuroxime |
| Package Description | 10 VIAL in 1 CARTON (25021-120-59) > 82.5 mL in 1 VIAL |
| Product NDC | 25021-120 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefuroxime sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080501 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFUROXIME SODIUM |
| Strength Number | 7.5 |
| Strength Unit | g/82.5mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |